ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE

Hormone-receptor positive breast cancer is the most common molecular subtype and represents 60–75 % of all breast cancers (BC). The presence of specific molecular targets such as the estrogen/progesterone receptor determines the use of hormone therapy for patients with this subtype. Tamoxifen, a sel...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: D. B. Erdyneeva, N. N. Babyshkina, T. A. Dronova, S. V. Vtorushin, E. M. Slonimskaya, V. N. Stegniy, N. V. Cherdyntseva
格式: Artigo
語言:Russo
出版: Tomsk National Research Medical Center of the Russian Academy of Sciences 2020-09-01
叢編:Sibirskij Onkologičeskij Žurnal
主題:
hormone-receptor positive breast cancer
cyclin d1
tamoxifen
resistance mechanisms
在線閱讀:https://www.siboncoj.ru/jour/article/view/1540
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍